Bellerophon (BLPH) just unveiled an update.
Bellerophon Therapeutics, Inc. is set to dissolve after a decisive shareholder vote favored the company’s liquidation, with the board now authorized to proceed according to the approved Plan of Liquidation and Dissolution. This significant move followed the immediate resignation of board members Mary Ann Cloyd and Dr. Scott Bruder, which was not due to any operational disagreements. The announcement comes after a special meeting where stockholders, representing over two-thirds of the voting power, reached a quorum and cast their votes, overwhelmingly supporting the company’s dissolution.
Find detailed analytics on BLPH stock on TipRanks’ Stock Analysis page.